The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Open accessAbstract
BACKGROUND: Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer. METHODS: Data from 13 ovarian cancer case-control studies, which were part of the Ovarian Cancer Association Consortium, were pooled and logistic regression analyses were undertaken to assess the association between self-reported endometriosis and risk of ovarian cancer. Analyses of invasive cases were done with respect to histological subtypes, grade, and stage, and analyses of borderline tumours by histological subtype. Age, ethnic origin, study site, parity, and duration of oral contraceptive use were included in all analytical models. FINDINGS: 13 226 controls and 7911 women with invasive ovarian cancer were included in this analysis. 818 and 738, respectively, reported a history of endometriosis. 1907 women with borderline ovarian cancer were also included in the analysis, and 168 of these reported a history of endometriosis. Self-reported endometriosis was associated with a significantly increased risk of clear-cell (136 [20·2%] of 674 cases vs 818 [6·2%] of 13 226 controls, odds ratio 3·05, 95% CI 2·43-3·84, p<0·0001), low-grade serous (31 [9·2%] of 336 cases, 2·11, 1·39-3·20, p<0·0001), and endometrioid invasive ovarian cancers (169 [13·9%] of 1220 cases, 2·04, 1·67-2·48, p<0·0001). No association was noted between endometriosis and risk of mucinous (31 [6·0%] of 516 cases, 1·02, 0·69-1·50, p=0·93) or high-grade serous invasive ovarian cancer (261 [7·1%] of 3659 cases, 1·13, 0·97-1·32, p=0·13), or borderline tumours of either subtype (serous 103 [9·0%] of 1140 cases, 1·20, 0·95-1·52, p=0·12, and mucinous 65 [8·5%] of 767 cases, 1·12, 0·84-1·48, p=0·45). INTERPRETATION: Clinicians should be aware of the increased risk of specific subtypes of ovarian cancer in women with endometriosis. Future efforts should focus on understanding the mechanisms that might lead to malignant transformation of endometriosis so as to help identify subsets of women at increased risk of ovarian cancer. FUNDING: Ovarian Cancer Research Fund, National Institutes of Health, California Cancer Research Program, California Department of Health Services, Lon V Smith Foundation, European Community's Seventh Framework Programme, German Federal Ministry of Education and Research of Germany, Programme of Clinical Biomedical Research, German Cancer Research Centre, Eve Appeal, Oak Foundation, UK National Institute of Health Research, National Health and Medical Research Council of Australia, US Army Medical Research and Materiel Command, Cancer Council Tasmania, Cancer Foundation of Western Australia, Mermaid 1, Danish Cancer Society, and Roswell Park Alliance Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“endometrioid cancer (OR 2.21)”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“It is becoming clear that epigenetics and genomic instability associated with the particular microenvironment of endometriosis characterized by oxidative stress, inflammatory process and high estrogen levels contribute to the process of malignant transformation of endometriosis (Pearce et al., 2012, Nezhat et al., 2014).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al., 2012
In the citing paper
“and low-grade serous invasive ovarian cancers (OR 2.21).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. (2012), concluded that self-reported endometriosis was associated with significantly increased risk for CCC [odds ratio (OR) 3.05]”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. summarized 13 case-control studies and reported the highest odds ratio of 3.05 for clear cell carcinoma, followed by LG-serous (2.11) and endometrioid carcinoma (2.04) in patients with endometriosis [9].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Malignant transformation of ovarian endometriosis has been well documented.”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“In population-based studies, the incidence of ovarian cancer in patients with a history of ovarian endometriosis is 1.35-1.49times greater compared with those without this history [9,10].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Of these, we observed associations with multiple diseases or traits, including epithelial ovarian cancer21, low-density lipoprotein cholesterol22, coronary heart disease23, luteinizing hormone and follicle-stimulating hormone levels, and age at onset for menopause24.”
From Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism (2017) · cites this paper as [21]
In the citing paper
“Most recently, in a study of 13 226 controls and 7911 women with invasive ovarian cancer, self-reported endometriosis was associated with a significantly increased risk of clear-cell, low-grade serous, and endometrioid invasive ovarian cancers.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“No association was noted between endometriosis and risk of mucinous or high-grade serous invasive ovarian cancer or borderline tumors of either subtype.118”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“Endometriosis and ovarian cancer have been linked by a number of studies.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“which have been (suggested to be) associated with endometriosis or its constituting symptoms in epidemiologic studies (51–54).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,890
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationEskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,099
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
Self-citationCancer risk after a hospital discharge diagnosis of endometriosis
Brinton, L. A., Gridley, G., Persson, I. R., Baron, J. A., & Bergqvist, A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70550-7 · Cited by 549
Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies
Ness, R. B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.3.217 · Cited by 425
Self-citationRisk of cancer after use of fertility drugs with in-vitro fertilisation
Venn, A., Watson, L., Bruinsma, F., Giles, G. G., & Healy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05203-4 · Cited by 368
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
Melin, A., Sparén, P., Persson, I., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei462 · Cited by 306
Cited by
Sorted by citations
Items 301–400 of 946
Long-Term Health Consequences of Endometriosis—Pathways and Mediation by Treatment
Farland, L. V., & Harris, H. R. (2020) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-020-00287-9 · Cited by 32
Impact of parity on the incidence of ovarian cancer subtypes: a population-based case–control study
Toufakis, V., Katuwal, S., Pukkala, ., & Tapanainen, J. S. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1919754 · Cited by 31
Robin, B., Planeix, F., Sastre‐Garau, X., Pichon, C., Olesen, T. K., Gogusev, J., & Ghinea, N. (2015) · Reproductive Sciences · doi:10.1177/1933719115623647 · Cited by 31
Bai, H., Cao, D., Yuan, F., Sha, G., Yang, J., Chen, J., Wang, Y., Zhang, Z., & Shen, K. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.10.009 · Cited by 31
Li, Q., Sun, Y., Zhang, X., Wang, L., Wu, W., Wu, M., Meng, C., & Liu, G. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1595278 · Cited by 30
Imaging for evaluation of endometriosis and adenomyosis
Bordonné, C., Puntonet, J., Maitrot‐Mantelet, L., Bourdon, M., Marcellin, L., Dion, É., Plu‐Bureau, G., Santulli, P., & Chapron, C. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04710-9 · Cited by 30
Bai, H., Sha, G., Xiao, M., Gao, H., Cao, D., Yang, J., Chen, J., Wang, Y., Zhang, Z., & Shen, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7216 · Cited by 30
RETRACTED ARTICLE: Targeted immune therapy of ovarian cancer
Knutson, K. L., Karyampudi, L., Lamichhane, P., & Preston, C. C. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9540-2 · Cited by 30
RetractedGenetic risk factors for ovarian cancer and their role for endometriosis risk
Burghaus, S., Fasching, P. A., Häberle, L., Rübner, M., Büchner, K., Blum, S., Engel, A., Ekici, A. B., Hartmann, A., Hein, A., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.02.022 · Cited by 29
Self-citationShigeta, S., Lui, G. Y. L., Shaw, R. C., Moser, R. D., Gurley, K. E., Durenberger, G., Rosati, R., Diaz, R. L., Ince, T. A., Swisher, E. M., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0809 · Cited by 29
Mikami, M., Tanabe, K., Matsuo, K., Miyazaki, Y., Miyazawa, M., Hayashi, M., Asai, S., Ikeda, M., Shida, M., Hirasawa, T., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.10.012 · Cited by 29
Matsuo, K., Moeini, A., Machida, H., Scannell, C. A., Casabar, J. K., Kakuda, M., Adachi, S., Garcia‐Sayre, J., Ueda, Y., & Roman, L. D. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4952-y · Cited by 29
Saavalainen, L., Lassus, H. J., But, A., Tiitinen, A. E., Härkki, P., Gissler, M., Heikinheimo, O., & Pukkala, . (2018) · International Journal of Cancer · doi:10.1002/ijc.31721 · Cited by 28
Birth weight, childhood body mass index and height and risks of endometriosis and adenomyosis
Aarestrup, J., Jensen, B. W., Ulrich, L. G., Hartwell, D., Trabert, B. L., & Baker, J. L. (2020) · Annals of Human Biology · doi:10.1080/03014460.2020.1727011 · Cited by 28
He, R., Liu, X., Zhang, J., Wang, Z., Wang, W., Fu, L., Fan, Y., Sun, S., Cao, Y., Zhan, L., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01281 · Cited by 29
Role of surgical treatment in endometriosis
D’Alterio, M. N., Saponara, S., D’Ancona, G., RUSSO, M., Laganà, A. S., Sorrentino, F., Nappi, L., & Angioni, S. L. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04737-7 · Cited by 30
A nonsynonymous variant of IL1A is associated with endometriosis in Japanese population
Hata, Y., Nakaoka, H., Yoshihara, K., Adachi, S., Haino, K., Yamaguchi, M., Nishikawa, N., Kashima, K., Yahata, T., Tajima, A., et al. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.32 · Cited by 28
Epithelial Ovarian Cancers and Endometriosis
Acién, P., Velasco, I., Acién, M., Capello, C., & Vela, P. (2015) · Gynecologic and Obstetric Investigation · doi:10.1159/000367597 · Cited by 28
Endometriosis for the primary care physician
Youngster, M., Laufer, M. R., & DiVasta, A. D. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283628092 · Cited by 29
Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases
Morgan, R. D., Burghel, G. J., Flaum, N., Bulman, M. P., Clamp, A. R., Hasan, J., Mitchell, C. L., Schlecht, H., Woodward, E. R., Lallo, F. I., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105792 · Cited by 28
Kelemen, L. E., Rambau, P., Koziak, J. M., Steed, H. L., & Köbel, M. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0855-5 · Cited by 27
Irvin, S., Clarke, M. A., Trabert, B. L., & Wentzensen, N. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01327-8 · Cited by 27
Ota, Y., Koizume, S., Nakamura, Y., Yoshihara, M., Takahashi, T., Sato, S., Myoba, S., Ohtake, N., Kato, H., Yokose, T., et al. (2021) · Oncology Reports · doi:10.3892/or.2021.7944 · Cited by 27
Centini, G., Schettini, G., Pieri, E., Giorgi, M., Lazzeri, L., Martire, F. G., Mancini, V., Raimondo, D., Seracchioli, R., Habib, N., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13071933 · Cited by 27
Vercellini, P., Cribiù, F. M., GOBBO, A. D., Carcangiu, M. L., Somigliana, E., & Bòsari, S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.02.002 · Cited by 27
High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population
Ingerslev, K., Høgdall, E. V. S., Skovrider‐Ruminski, W., Schnack, T. H., Karlsen, M. A., Nedergaard, L., Høgdall, C. K., & Blaakær, J. (2016) · Infectious Agents and Cancer · doi:10.1186/s13027-016-0087-4 · Cited by 27
Endometriosis and its global research architecture: an in-depth density-equalizing mapping analysis
Brüggmann, D., Elizabeth-Martinez, A., Klingelhöfer, D., Quarcoo, D., Jaque, J. M., & Groneberg, D. A. (2016) · BMC Women s Health · doi:10.1186/s12905-016-0336-0 · Cited by 27
Nagasawa, S., Ikeda, K., Horie‐Inoue, K., Sato, S., Itakura, A., Takeda, S., Hasegawa, K., & Inoue, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184330 · Cited by 27
Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma
Shin, H., Yang, W., Chay, D. B., Lee, E., Chung, J., Kim, H., & Kim, J. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12884 · Cited by 27
Clyde, M. A., Weber, R. P., Iversen, E. S., Poole, E. M., Doherty, J. A., Goodman, M. T., Ness, R. B., Risch, H. A., Rossing, M. A., Terry, K. L., et al. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww091 · Cited by 26
Self-citationGenetic links between endometriosis and cancers in women
Bhyan, S. B., Zhao, L., Wee, Y., Liu, Y., & Zhao, M. (2019) · PeerJ · doi:10.7717/peerj.8135 · Cited by 27
The Many Faces of Endometriosis-Related Neoplasms in the Same Patient: A Brief Report
Santoro, A., Angelico, G., Inzani, F. S., Spadola, S., Arciuolo, D., Valente, M., Fiorentino, V., Mulè, A., Scambia, G., & Zannoni, G. F. (2020) · Gynecologic and Obstetric Investigation · doi:10.1159/000508225 · Cited by 26
Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma
Yamaguchi, K. D., Kitamura, S., Furutake, Y., Murakami, R., Yamanoi, K., Taki, M., Ukita, M., Hamanishi, J., & Mandai, M. (2021) · Cancers · doi:10.3390/cancers13102413 · Cited by 26
Study, A. C., Earp, M. A., Australian Ovarian Cancer Study Group, Kelemen, L. E., Magliocco, A. M., Swenerton, K. D., Chenevix‐Trench, G., Lu, Y., Hein, A., Ekici, A. B., et al. (2013) · Human Genetics · doi:10.1007/s00439-013-1383-3 · Cited by 26
Self-citationAnastasi, E., Manganaro, L., Granato, T., Panici, P. B., Frati, L., & Porpora, M. G. (2013) · Disease Markers · doi:10.1155/2013/984641 · Cited by 26
Interdisciplinary S2k Guidelines for the Diagnosis and Treatment of Endometriosis
Ulrich, U. A., Buchweitz, O., Greb, R. R., Keckstein, J., von Leffern, I., Oppelt, P., Renner, S. P., Sillem, M., Stummvoll, W., & Schweppe, K.-W. (2013) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0033-1350810 · Cited by 26
Increased association of ovarian cancer in women with histological proven endosalpingiosis
Hermens, M., van Altena, A. M., Bulten, J., Siebers, A. G., & Bekkers, R. L. M. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101700 · Cited by 26
Endometrial Cancer Incidence in Endometriosis and Adenomyosis
Hermens, M., van Altena, A. M., Velthuis, I., van de Laar, D. C. M., Bulten, J., van Vliet, H. A. A. M., Siebers, A. G., & Bekkers, R. L. M. (2021) · Cancers · doi:10.3390/cancers13184592 · Cited by 26
Yoshikawa, N., Yoshida, K., Tamauchi, S., Ikeda, Y., Nishino, K., Niimi, K., Suzuki, S., Kikkawa, F., & Kajiyama, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-64171-5 · Cited by 25
Endometriosis: A Role for Stem Cells
Dhesi, A. S., & Morelli, S. S. (2015) · Women s Health · doi:10.2217/whe.14.57 · Cited by 25
A mass spectrometric insight into the origins of benign gynecological disorders
Yang, H., Lau, W. B., Lau, B., Yu, X., Zhou, S., Zhao, L., Luo, Z., Lin, Q., Ren, N., Zhao, X., et al. (2015) · Mass Spectrometry Reviews · doi:10.1002/mas.21484 · Cited by 25
Low-grade epithelial ovarian cancer
Oswald, A. J., & Gourley, C. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000216 · Cited by 25
Concomitant endometriosis in malignant and borderline ovarian tumours*
Oral, E., Aydın, Ö., Kumbak, B., İlvan, Ş., Yilmaz, H., Tustas, E., Beşe, T., Demirkıran, F., & Arvas, M. (2018) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1441815 · Cited by 25
Differential Expression of KRAS and SIRT1 in Ovarian Cancers with and Without Endometriosis
Teasley, H. E., Beesley, A., Kim, T. H., Risinger, J. I., Young, S. L., Jeong, J., Schammel, D. P., Lessey, B. A., Elder, J. W., & Puls, L. E. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00017-4 · Cited by 25
Jang, J. Y. A., Yanaihara, N., Pujade-Lauraine, É., Mikami, Y., Oda, K., Bookman, M. A., Ledermann, J. A., Shimada, M., Kiyokawa, T., Kim, B., et al. (2017) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2017.28.e54 · Cited by 25
Kim, H. S., Kim, M. A., Lee, M., Suh, D. H., Kim, K., No, J. H., Chung, H. H., Kim, Y. B., & Song, Y. S. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4319-9 · Cited by 25
Turner, T. B., Secord, A. A., Lowery, W. J., Sfakianos, G. P., & Lee, P. S. (2013) · Gynecologic Oncology Case Reports · doi:10.1016/j.gynor.2013.03.002 · Cited by 24
Complications des tumeurs ovariennes présumées bénignes
Deffieux, X., Thubert, T., Huchon, C., Demoulin, G., Rivain, A.-L., Faivre, E., & Trichot, C. (2013) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2013.09.036 · Cited by 24
Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells
Kapur, A., Ayuso, J. M., Rehman, S., Kumari, S., Felder, M. A. R., Stenerson, Z., Skala, M. C., Beebe, D., Barroilhet, L. M., & Patankar, M. S. (2023) · Reproduction · doi:10.1530/rep-22-0265 · Cited by 24
Wang, X., Ivan, M., & Hawkins, S. M. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.08.027 · Cited by 24
Glubb, D. M., Thompson, D., Aben, K., Alsulimani, A., Amant, F., Annibali, D., Attia, J., Barricarte, A., Beckmann, M. W., Berchuck, A., et al. (2020) · Cancer Epidemiology, Biomarkers and Prevention · doi:10.1158/1055-9965.epi-20-0739 · Cited by 20
Self-citationFuningana, I.-G., Reinius, M. A. V., Petrillo, A., Ang, J. E., & Brenton, J. D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.008 · Cited by 23
Rehmer, J. M., Flyckt, R. L., Goodman, L. R., & Falcone, T. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000660 · Cited by 23
Su, K., Lin, T.-W., Liu, L., Yang, Y., Wang, M., Tsai, P., Wang, P., Yu, M.-H., Chang, C.-M., & Chang, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082824 · Cited by 23
Lee, H. J., Lee, B., Choi, H., Kim, T., Kim, Y., & Kim, Y. B. (2023) · Cancers · doi:10.3390/cancers15061708 · Cited by 23
Pelvic Inflammation and the Pathogenesis of Ovarian Cancer
McAlpine, J. N., Lisonkova, S., Joseph, K. S., & McComb, P. F. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000235 · Cited by 23
Targeting Src in endometriosis-associated ovarian cancer
Manek, R., Pakzamir, E., Mhawech-Fauceglia, P. Y., Pejovic, T. B., Sowter, H., Gayther, S. A., & Lawrenson, K. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.54 · Cited by 23
Self-citationRecent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer
Mills, K., & Fuh, K. C. (2017) · F1000Research · doi:10.12688/f1000research.9977.1 · Cited by 23
LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers
Xia, Z., Cochrane, D. R., Anglesio, M. S., Wang, Y. K., Nazeran, T. M., Tessier‐Cloutier, B., McConechy, M. K., Senz, J., Lum, A. M., Bashashati, A., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.09.032 · Cited by 23
Self-citationZhao, T., Shao, Y., Liu, Y., Wang, X., Guan, L., & Lu, Y. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0425-9 · Cited by 23
Ponandai‐Srinivasan, S., Andersson, K. L., Nistér, M., Saare, M., Hassan, H. A., Varghese, S. J., Peters, M., Salumets, A., Gemzell‐Danielsson, K., & Lalitkumar, P. G. (2018) · Human Reproduction · doi:10.1093/humrep/dey241 · Cited by 24
Altayyeb, A., Othman, E. R., Khashbah, M. Y., Esmaeel, A., El‐Mokhtar, M. A., Lambalk, C. B., Mijatovic, V., & Abdelgawad, M. O. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00042-3 · Cited by 23
Zeppernick, F. A., Zeppernick, M. M., Janschek, E., Wölfler, M. M., Bornemann, S., Holtmann, L., Oehmke, F., Brandes, I., Scheible, C. M., Salehin, D., et al. (2020) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1068-9260 · Cited by 23
McGuinness, B. G., Nezhat, F. R., Ursillo, L., Akerman, M. B., Vintzileos, W. S., & White, M. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.05.026 · Cited by 23
The Endometrioma Treatment Paradigm when Fertility Is Desired: A Systematic Review
Miller, C. E. (2020) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2020.11.020 · Cited by 23
Marques, C., Silva, T. S., & Dias, M. F. (2017) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2017.03.008 · Cited by 22
“We present a clinical case of clear cell carcinoma of the abdominal wall related to endometriosis neoplastic transformation.”
BackgroundPejovic, T. B., Cathcart, A. M., Alwaqfi, R., Brooks, M. N., Kelsall, R., & Nezhat, F. R. (2024) · Life · doi:10.3390/life14060704 · Cited by 22
Factors in malignant transformation of ovarian endometriosis: A narrative review
Giannini, A., Massimello, F., Caretto, M., Cosimi, G., Mannella, P., Luisi, S. V., Gadducci, A., & Simoncini, T. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2409911 · Cited by 23
Kho, R. M., & Wechter, M. E. (2016) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2016.12.004 · Cited by 22
Ju, U. C., Kang, W. D., & Kim, S. M. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12861 · Cited by 22
Li, B., Wang, Y., Wang, Y., Li, S., & Liu, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.832228 · Cited by 22
Younis, J. S. (2022) · Biomolecules · doi:10.3390/biom12111721 · Cited by 22
Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment
Zhao, X., Liu, Z., & Chen, T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030948 · Cited by 25
Hablase, R., Kyrou, I., Randeva, H. S., Karteris, E., & Chatterjee, J. (2024) · Cancers · doi:10.3390/cancers16112160 · Cited by 24
Prospects for potential therapy targeting immune‑associated factors in endometriosis (Review)
Zhang, W., Li, K., Jian, A., Zhang, G., & Zhang, X. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13422 · Cited by 25
Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin
Kotsopoulos, J., Terry, K. L., Poole, E. M., ROSNER, B. A., Murphy, M., Hecht, J. L., Crum, C. P., Missmer, S. A., Cramer, D. W., & Tworoger, S. S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28064 · Cited by 22
Self-citationFertility drug use and risk of ovarian tumors: a debated clinical challenge
Gadducci, A., Guerrieri, M. E., & Genazzani, A. R. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.705382 · Cited by 22
Value of HE4 combined with cancer Antigen 125in the diagnosis of Endometrial Cancer
Dong, C., Liu, P., & Li, C. (2017) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.334.12755 · Cited by 22
Ponandai‐Srinivasan, S., Saare, M., Boggavarapu, N. R., Frisendahl, C., Ehrström, S., Riethmüller, C., García-Uribe, P. Á., Rettkowski, J., Iyengar, A. S., Salumets, A., et al. (2020) · Human Reproduction · doi:10.1093/humrep/deaa164 · Cited by 22
Ishikawa, M., Nakayama, K., Nakamura, K., Ono, R., Sanuki, K., Yamashita, H., Ishibashi, T., Minamoto, T., Iida, K., Razia, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24546 · Cited by 22
Brassica Bioactives Could Ameliorate the Chronic Inflammatory Condition of Endometriosis
García-Ibáñez, P., Yepes‐Molina, L., Ruiz‐Alcaraz, A. J., Martinez‐Esparza, M., Moreno, D. A., Carvajal, M., & García–Peñarrubia, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249397 · Cited by 21
Chang, C. S., Carney, M. E., & Killeen, J. L. (2022) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000863 · Cited by 21
Self-citationPrognostic markers of inflammation in endometrioid and clear cell ovarian cancer
Gallego, A., Mendiola, M., Hernando, B., Berjón, A., Cádiz, A., Chaves-Urbano, B., Heredia-Soto, V., Spagnolo, E., Hernández, A., Hardisson, D., et al. (2022) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2022-003353 · Cited by 21
Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis
Collins, K. E., Wang, X., Klymenko, Y., Davis, N. B., Martinez, M. C., Zhang, C., So, K., Buechlein, A. M., Rusch, D. B., Creighton, C. J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1162786 · Cited by 21
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma
Linder, A., Westbom-Fremer, S., Mateoiu, C., Widjaja, A., Österlund, T., Veerla, S., Ståhlberg, A., Ulfenborg, B., Hedenfalk, I. A., & Sundfeldt, K. (2024) · Human Reproduction · doi:10.1093/humrep/deae043 · Cited by 23
Clinical implication for endometriosis associated with ovarian cancer
Torng, P. (2017) · Gynecology and Minimally Invasive Therapy · doi:10.1016/j.gmit.2017.08.003 · Cited by 21
Epidemiological and Clinical Risk Factors for Endometriosis
Farland, L. V., Shah, D. K., Kvaskoff, M., Zondervan, K. T., & Missmer, S. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-59856-7_6 · Cited by 21
Trabert, B. L., Coburn, S. B., Falk, R. T., Manson, J. E., Brinton, L. A., Gass, M. L. S., Kuller, L. H., Rohan, T. E., Pfeiffer, R. M., Qi, L., et al. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01233-8 · Cited by 21
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
Amano, T., Murakami, A., Murakami, T., & Chano, T. (2021) · Antioxidants · doi:10.3390/antiox10020187 · Cited by 21
Tamura, R., Yoshihara, K., & Enomoto, T. (2022) · Cancers · doi:10.3390/cancers14092125 · Cited by 21
Park, W., Park, M. Y., Song, G., & Lim, W. (2020) · Phytotherapy Research · doi:10.1002/ptr.6677 · Cited by 20
A prognostic system for epithelial ovarian carcinomas using machine learning
Grimley, P. M., Liu, Z., Darcy, K. M., Hueman, M. T., Wang, H., Li, S., Henson, D. E., & Chen, D. (2021) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14137 · Cited by 20
Increased incidence of ovarian cancer in both endometriosis and adenomyosis
Hermens, M., van Altena, A. M., Bulten, J., van Vliet, H. A. A. M., Siebers, A. G., & Bekkers, R. L. M. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.07.006 · Cited by 20
An, T., Di, X., Zhao, X., & Liang, X. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.952379 · Cited by 22
Vehmas, A. P., Muth‐Pawlak, D., Huhtinen, K., Saloniemi-Heinonen, T., Jaakkola, K., Laajala, T. D., Kaprio, H., Suvitie, P. A., Aittokallio, T. A., Siitari, H., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr500384n · Cited by 20
Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer
Merritt, M. A., Poole, E. M., Hankinson, S. E., Willett, W. C., & Tworoger, S. S. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0381-7 · Cited by 21
Improved clinical outcomes of patients with ovarian carcinoma arising in endometriosis
Lu, J., Tao, X., Zhou, J., Lu, Y., Wang, Z., Liu, H., & Xu, C. (2016) · Oncotarget · doi:10.18632/oncotarget.13967 · Cited by 20
Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer
Yu-Rice, Y., Edassery, S. L., Urban, N. D., Hellström, I., Hellström, K. E., Deng, Y., Li, Y., & Luborsky, J. L. (2016) · Reproduction · doi:10.1530/rep-16-0265 · Cited by 20
Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses
Hoare, J. I., Campbell, N., & Carapuça, E. (2018) · Porto Biomedical Journal · doi:10.1016/j.pbj.0000000000000007 · Cited by 20
Yin, X., Bi, R., Ma, P., Zhang, S., Zhang, Y., Sun, Y., Zhang, Y., Jing, Y., Yu, M., Wang, W., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106418 · Cited by 21
Metadata
- Authors
- Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., Chang-Claude, J., Hein, R., Lurie, G., Wilkens, L. R., Carney, M. E., Goodman, M. T., Moysich, K., Kjaer, S. K., Hogdall, E., Jensen, A., Goode, E. L., Fridley, B. L., Larson, M. C., Schildkraut, J. M., Palmieri, R. T., Cramer, D. W., Terry, K. L., Vitonis, A. F., Titus, L. J., Ziogas, A., Brewster, W., Anton-Culver, H., Gentry-Maharaj, A., Ramus, S. J., Anderson, A. R., Brueggmann, D., Fasching, P. A., Gayther, S. A., Huntsman, D. G., Menon, U., Ness, R. B., Pike, M. C., Risch, H., Wu, A. H., & Berchuck, A.
- Affiliations
- University of Southern California (US)
- Fred Hutch Cancer Center (US)
- Georgetown University Medical Center (US)
- QIMR Berghofer Medical Research Institute (AU)
- German Cancer Research Center (DE)
- University of Hawaiʻi at Mānoa (US)
- Roswell Park Comprehensive Cancer Center (US)
- Danish Cancer Society (DK)
- Mayo Clinic (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Dartmouth College (US)
- University of California, Irvine (US)
- University of North Carolina at Chapel Hill (US)
- University College London (GB)
- University of California, Los Angeles (US)
- Yale University (US)
- Corresponding author
- Pearce, Celeste Leigh
- ORCID
- Pearce, Celeste Leigh
- Lee, Alice
- Near, Aimee M
- Webb, Penelope M
- Nagle, Christina M
- Doherty, Jennifer A
- Wicklund, Kristine G
- Wilkens, Lynne R
- Goodman, Marc T
- Moysich, Kirsten
- Jensen, Allan
- Goode, Ellen L
- Fridley, Brooke L
- Larson, Melissa C
- Schildkraut, Joellen M
- Cramer, Daniel W
- Terry, Kathryn L
- Titus, Linda J
- Ziogas, Argyrios
- Brewster, Wendy
- Ramus, Susan J
- Fasching, Peter A
- Gayther, Simon A
- Menon, Usha
- Pike, Malcolm C
- Risch, Harvey
- Wu, Anna H
- Berchuck, Andrew
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 13
- Issue
- 4
- Pages
- 385-394
- ISSN
- 1470-2045 (ISSN-L)
- PMC
- PMC3664011
- OpenAlex
- W2125681453
- Cited by
- 939
- References
- 43
- Citations by year
- 2026: 47 · 2025: 53 · 2024: 46 · 2023: 64 · 2022: 44 · 2021: 84 · 2020: 88 · 2019: 77 · 2018: 71 · 2017: 83 · 2016: 68 · 2015: 65 · 2014: 55 · 2013: 68 · 2012: 26
- FWCI
- 79.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- California Breast Cancer Research Program (0001389V20170, 2110200)
- Seventh Framework Programme (HEALTH-F2-2009-223175)
- University of South China
- National Institutes of Health (5R01 CA074850, CA14089, CA17054, CA58860, CA61132, CA92044, N01 CN67001, N01 PC35137, N01 PC67010, P50 CA105009, P50 CA136393, PSA 042205, R01 CA112523, R01 CA122443, R01 CA126841, R01 CA136891, R01 CA54419, R01 CA58598, R01 CA61107, R01 CA76016, R01 CA87538, R01 CA95023, R03 CA113148)
- Medical Research and Materiel Command (DAMD 170110729, DAMD17-02-1-0669, W81XWH0610220, W81XWH1010280)
- Oak Foundation
- Lon V. Smith Foundation (LVS 39420)
- California Department of Public Health (050E8709)
- Roswell Park Alliance Foundation, Roswell Park Cancer Institute
- Kræftens Bekæmpelse
- Deutsches Krebsforschungszentrum
- National Health and Medical Research Council (199600)
- Cancer Council Tasmania
- American University of Sharjah
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- endometriosis, ovarian cancer, histological subtypes, ovarian clear cell carcinoma, low-grade serous ovarian cancer, endometrioid ovarian cancer, mucinous ovarian carcinoma, high-grade serous ovarian cancer, borderline ovarian tumors, cancer risk factors, oral contraceptive use, parity, tumor stage and grade, Ovarian Cancer Association Consortium
- MeSH terms
- Aged, Aged, 80 and over, Endometriosis, Ethnicity, Female, Humans, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Ovarian Neoplasms, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
